Tapia Contreras C, Falke JD, Seifert DM, et al. KRAS(G) (12C)-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening (PMID: 39253995). Mol Oncol. 2025.
Category: Publication
Characterization of single neurons reprogrammed by pancreatic cancer
Thiel V, Renders S, Panten J, et al. Characterization of single neurons reprogrammed by pancreatic cancer (PMID: 39961335). Nature. 2025.
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signaling
Wurth R, Donato E, Michel LL, et al. Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signaling (PMID: 39753722). Nat Cancer. 2025.
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma
Zhao B, Fang R, Schurmann H, et al. PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma (PMID: 40188436). Cell Rep. 2025.
Multimodal survival prediction in advanced pancreatic cancer using machine learning
Keyl J, Kasper S, Wiesweg M, et al. Multimodal survival prediction in advanced pancreatic cancer using machine learning (PMID: 35988455). ESMO Open. Epub 2022.
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma
Heid I, Münch C, Karakaya S, et al. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma (PMID: 36494842). Cancer Metab. 2022.
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
Wiedmann L, De Angelis Rigotti F, Vaquero-Siguero N, et al. HAPLN1 potentiates peritoneal metastasis in pancreatic cancer (PMID: 37095087). Nat Commun. 2023.
Approaches for single-cell RNA sequencing across tissues and cell types
Sant P, Rippe K and Mallm JP. Approaches for single-cell RNA sequencing across tissues and cell types (PMID: 37062951). Transcription. 2023.
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer
Saini M, Schmidleitner L, Moreno HD, et al. Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer (PMID: 37257449). Cell Rep. Epub 2023.
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer
Reissig TM, Tzianopoulos I, Liffers ST, et al. Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer (PMID: 37148593). ESMO Open. Epub 2023.
